Ondansetron ODT 8 mg (Ondansetron TABLET (ORALLY DISINTEGRATING)) 8 MG

ONDANSETRON ODT 8 MG is an orally disintegrating tablet designed to provide quick relief. This medication is commonly used to manage nausea and vomiting, offering a convenient alternative to traditional tablets.

Strength

8 MG

Manufacturer / TM Owner

JAMP PHARMA CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ONDANSETRON ODT 8 MG is primarily used for the prevention and treatment of nausea and vomiting. It is often prescribed for patients undergoing chemotherapy or radiation therapy, as well as for postoperative nausea and vomiting. The orally disintegrating form allows for easy administration, making it a suitable option for those who have difficulty swallowing pills.

Side Effects

Common effects of ONDANSETRON ODT 8 MG may include headache, constipation, and dizziness. Some users might experience dry mouth or fatigue. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Precautions & Warnings

ONDANSETRON ODT 8 MG should be used with caution in patients with a history of heart conditions or electrolyte imbalances. It is important to follow the prescribed dosage and administration instructions. Keep the medication out of reach of children and store it as directed.

Avoid Interactions

ONDANSETRON ODT 8 MG may interact with certain medications, including apomorphine and other drugs that affect serotonin levels. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.

Frequently Asked Questions

ONDANSETRON ODT 8 MG is used to prevent and treat nausea and vomiting, often associated with chemotherapy, radiation therapy, or surgery.

The orally disintegrating form of ONDANSETRON dissolves quickly in the mouth, allowing for easy administration without the need for water.

Common side effects may include headache, constipation, dizziness, dry mouth, and fatigue.

It is important to consult a healthcare provider before taking ONDANSETRON ODT 8 MG with other medications to avoid potential interactions.

The safety of ONDANSETRON ODT 8 MG in children should be discussed with a healthcare provider, as it may vary depending on the specific situation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.